Cargando…
Correction to: Efficacy and safety of remimazolam besylate versus propofol during hysteroscopy: single-centre randomized controlled trial
Autores principales: | Zhang, Xiaoqiang, Li, Shuang, Liu, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212503/ https://www.ncbi.nlm.nih.gov/pubmed/34144683 http://dx.doi.org/10.1186/s12871-021-01390-x |
Ejemplares similares
-
Efficacy and safety of remimazolam besylate versus propofol during hysteroscopy: single-centre randomized controlled trial
por: Zhang, Xiaoqiang, et al.
Publicado: (2021) -
Remimazolam Compared to Propofol During Hysteroscopy: A Safety and Efficacy Analysis
por: Fan, Shunyi, et al.
Publicado: (2023) -
Remimazolam-remifentanil causes less postoperative nausea and vomiting than remimazolam-alfentanil during hysteroscopy: a single-centre randomized controlled trial
por: Zhang, Xiaoqiang, et al.
Publicado: (2023) -
Remimazolam besylate versus propofol for deep sedation in critically ill patients: a randomized pilot study
por: Tang, Yun, et al.
Publicado: (2023) -
Remimazolam Tosylate Combined with Low-Dose Propofol Improves Sedation and Safety in Hysteroscopy
por: Zhang, Fan, et al.
Publicado: (2022)